ORELABRUTINIB vs OSIMERTINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
ORELABRUTINIB vs OSIMERTINIB: Safety Overview
| Metric | ORELABRUTINIB | OSIMERTINIB |
|---|---|---|
| Total FAERS Reports | 131 | 27,750 |
| Deaths Reported | 29 | 12,456 |
| Death Rate | 22.1% | 44.9% |
| Hospitalizations | 12 | 5,277 |
| Average Patient Age | 66.0 yrs | 68.2 yrs |
| % Female Patients | 63.8% | 66.0% |
| FDA Approval Date | N/A | Nov 13, 2015 |
| Manufacturer | N/A | AstraZeneca Pharmaceuticals LP |
| Route | N/A | ORAL |
| Marketing Status | N/A | Prescription |